Logo image of CRBN.AS

CORBION NV (CRBN.AS) Stock Price, Quote, News and Overview

AMS:CRBN - Euronext Amsterdam - NL0010583399 - Common Stock - Currency: EUR

18.34  +0.05 (+0.27%)

CRBN.AS Quote, Performance and Key Statistics

CORBION NV

AMS:CRBN (4/25/2025, 7:00:00 PM)

18.34

+0.05 (+0.27%)

Sector
GICS SectorMaterials
GICS IndustryChemicals
GICS IndustryGroupMaterials
GICS SubIndustrySpecialty Chemicals
Statistics
52 Week High26.98
52 Week Low16.64
Market Cap1.07B
Shares58.25M
Float58.01M
Yearly Dividend0.71
Dividend Yield3.5%
PE5.64
Fwd PE11.73
Earnings (Next)07-31 2025-07-31
IPO01-04 1999-01-04


CRBN.AS short term performance overview.The bars show the price performance of CRBN.AS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20

CRBN.AS long term performance overview.The bars show the price performance of CRBN.AS in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of CRBN.AS is 18.34 EUR. In the past month the price decreased by -8.76%. In the past year, price decreased by -4.88%.

CORBION NV / CRBN Daily stock chart

CRBN.AS Competitors/Peers

The largest stocks on the EU markets in the "Specialty Chemicals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
DSFIR.AS DSM-FIRMENICH AG 98.85 24.69B
6D81.DE DUPONT DE NEMOURS INC 16.11 24.14B
BRG.OL BORREGAARD ASA 20.51 16.90B
SY1.DE SYMRISE AG 28.56 13.65B
ELK.OL ELKEM ASA 24.67 12.30B
1COV.DE COVESTRO AG N/A 11.15B
AKZA.AS AKZO NOBEL N.V. 18.41 9.62B
EVK.DE EVONIK INDUSTRIES AG 24.63 9.07B
SYENS.BR SYENSQO SA 11.44 6.29B
AMC.DE ALBEMARLE CORP N/A 5.90B
AKE.PA ARKEMA 8.04 5.02B
WCH.DE WACKER CHEMIE AG 14.32 3.61B

About CRBN.AS

Company Profile

CRBN logo image Corbion NV engages in the development, production, sale, and distribution of ingredients for food and biochemicals. The company is headquartered in Amsterdam, Noord-Holland and currently employs 2,399 full-time employees. The company operates through two segments: Biobased Ingredients and Biobased Innovations. The Biobased Ingredients segment comprises the Food business division and the Biochemicals business division. The Food business division develops preservation ingredients and microbial spoilage prevention products for the baking, meat, dairy, confectionery and beverage industries, and the Biochemicals business division produces bio-based chemicals derived from renewable resources such as sugar or starch. The Biobased Innovations segment creates new biotechnology business platforms, such aspoly lactic acid (PLA). The firm operates production sites in the United States, Brazil, Spain, the Netherlands and Thailand, and markets its products through a global network of retail offices.

Company Info

CORBION NV

Piet Heinkade 127

Amsterdam NOORD-HOLLAND NL

Employees: 2727

Company Website: https://www.corbion.com/

Investor Relations: http://www.corbion.com/investor-relations

Phone: 31205906911

CORBION NV / CRBN.AS FAQ

What is the stock price of CORBION NV today?

The current stock price of CRBN.AS is 18.34 EUR. The price increased by 0.27% in the last trading session.


What is the ticker symbol for CORBION NV stock?

The exchange symbol of CORBION NV is CRBN and it is listed on the Euronext Amsterdam exchange.


On which exchange is CRBN.AS stock listed?

CRBN.AS stock is listed on the Euronext Amsterdam exchange.


What is the price forecast or stock price prediction for CORBION NV stock?

13 analysts have analysed CRBN.AS and the average price target is 26.08 EUR. This implies a price increase of 42.22% is expected in the next year compared to the current price of 18.34. Check the CORBION NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is CORBION NV worth?

CORBION NV (CRBN.AS) has a market capitalization of 1.07B EUR. This makes CRBN.AS a Small Cap stock.


How many employees does CORBION NV have?

CORBION NV (CRBN.AS) currently has 2727 employees.


What are the support and resistance levels for CORBION NV (CRBN.AS) stock?

CORBION NV (CRBN.AS) has a support level at 17.39 and a resistance level at 21.08. Check the full technical report for a detailed analysis of CRBN.AS support and resistance levels.


Is CORBION NV (CRBN.AS) expected to grow?

The Revenue of CORBION NV (CRBN.AS) is expected to grow by 3.15% in the next year. Check the estimates tab for more information on the CRBN.AS EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy CORBION NV (CRBN.AS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CORBION NV (CRBN.AS) stock pay dividends?

CORBION NV (CRBN.AS) has a dividend yield of 3.5%. The yearly dividend amount is currently 0.71. Check the full fundamental report for a detailed analysis of CRBN.AS dividend history, reliability and sustainability.


When does CORBION NV (CRBN.AS) report earnings?

CORBION NV (CRBN.AS) will report earnings on 2025-07-31.


What is the Price/Earnings (PE) ratio of CORBION NV (CRBN.AS)?

The PE ratio for CORBION NV (CRBN.AS) is 5.64. This is based on the reported non-GAAP earnings per share of 3.25 and the current share price of 18.34 EUR. Check the full fundamental report for a full analysis of the valuation metrics for CRBN.AS.


CRBN.AS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

CRBN.AS Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to CRBN.AS. While CRBN.AS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CRBN.AS Financial Highlights

Over the last trailing twelve months CRBN.AS reported a non-GAAP Earnings per Share(EPS) of 3.25. The EPS increased by 168.39% compared to the year before.


Industry RankSector Rank
PM (TTM) 14.92%
ROA 12.43%
ROE 24.88%
Debt/Equity 0.4
Chartmill High Growth Momentum
EPS Q2Q%-47.64%
Sales Q2Q%4.6%
EPS 1Y (TTM)168.39%
Revenue 1Y (TTM)1.9%

CRBN.AS Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 78% to CRBN.AS. The Buy consensus is the average rating of analysts ratings from 13 analysts.

For the next year, analysts expect an EPS growth of 55.4% and a revenue growth 3.15% for CRBN.AS


Ownership
Inst Owners77.4%
Ins Owners0.21%
Short Float %N/A
Short RatioN/A
Analysts
Analysts78.46
Price Target26.08 (42.2%)
EPS Next Y55.4%
Revenue Next Year3.15%